001     134821
005     20240229105042.0
024 7 _ |a 10.1016/j.kint.2018.01.008
|2 doi
024 7 _ |a pmid:29656901
|2 pmid
024 7 _ |a 0085-2538
|2 ISSN
024 7 _ |a 1523-1755
|2 ISSN
024 7 _ |a 2157-1716
|2 ISSN
024 7 _ |a 2157-1724
|2 ISSN
024 7 _ |a altmetric:38167747
|2 altmetric
037 _ _ |a DKFZ-2018-00611
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Brück, Katharina
|b 0
245 _ _ |a Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.
260 _ _ |a Basingstoke
|c 2018
|b Nature Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1529307775_27070
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The incidence of renal replacement therapy varies across countries. However, little is known about the epidemiology of chronic kidney disease (CKD) outcomes. Here we describe progression and mortality risk of patients with CKD but not on renal replacement therapy at outpatient nephrology clinics across Europe using individual data from nine CKD cohorts participating in the European CKD Burden Consortium. A joint model assessed the mean change in estimated glomerular filtration rate (eGFR) and mortality risk simultaneously, thereby accounting for mortality risk when estimating eGFR decline and vice versa, while also correcting for the measurement error in eGFR. Results were adjusted for important risk factors (baseline eGFR, age, sex, albuminuria, primary renal disease, diabetes, hypertension, obesity and smoking) in 27,771 patients from five countries. The adjusted mean annual eGFR decline varied from 0.77 (95% confidence interval 0.45, 1.08) ml/min/1.73m2 in the Belgium cohort to 2.43 (2.11, 2.75) ml/min/1.73m2 in the Spanish cohort. As compared to the Italian PIRP cohort, the adjusted mortality hazard ratio varied from 0.22 (0.11, 0.43) in the London LACKABO cohort to 1.30 (1.13, 1.49) in the English CRISIS cohort. These results suggest that the eGFR decline showed minor variation but mortality showed the most variation. Thus, different health care organization systems are potentially associated with differences in outcome of patients with CKD within Europe. These results can be used by policy makers to plan resources on a regional, national and European level.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Jager, Kitty J
|b 1
700 1 _ |a Zoccali, Carmine
|b 2
700 1 _ |a Bello, Aminu K
|b 3
700 1 _ |a Minutolo, Roberto
|b 4
700 1 _ |a Ioannou, Kyriakos
|b 5
700 1 _ |a Verbeke, Francis
|b 6
700 1 _ |a Völzke, Henry
|b 7
700 1 _ |a Arnlöv, Johan
|b 8
700 1 _ |a Leonardis, Daniela
|b 9
700 1 _ |a Ferraro, Pietro Manuel
|b 10
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 11
|u dkfz
700 1 _ |a Caplin, Ben
|b 12
700 1 _ |a Kalra, Philip A
|b 13
700 1 _ |a Wanner, Christoph
|b 14
700 1 _ |a Castelao, Alberto Martinez
|b 15
700 1 _ |a Gorriz, Jose Luis
|b 16
700 1 _ |a Hallan, Stein
|b 17
700 1 _ |a Rothenbacher, Dietrich
|b 18
700 1 _ |a Gibertoni, Dino
|b 19
700 1 _ |a De Nicola, Luca
|b 20
700 1 _ |a Heinze, Georg
|b 21
700 1 _ |a Van Biesen, Wim
|b 22
700 1 _ |a Stel, Vianda S
|b 23
700 1 _ |a Consortium, European CKD Burden
|b 24
|e Collaboration Author
773 _ _ |a 10.1016/j.kint.2018.01.008
|g Vol. 93, no. 6, p. 1432 - 1441
|0 PERI:(DE-600)2007940-0
|n 6
|p 1432 - 1441
|t Kidney international
|v 93
|y 2018
|x 0085-2538
909 C O |o oai:inrepo02.dkfz.de:134821
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b KIDNEY INT SUPPL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b KIDNEY INT : 2015
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b KIDNEY INT SUPPL : 2015
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l Klinische Epidemiologie und Alternsforschung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21